Market Research

Microtome Market Trends, Opportunities, Recent Industry Size And Share Analysis With Forecast To 2027

Jun 20, 2020 11:00 AM ET

iCrowd Newswire – Jun 20, 2020

The microtome market was valued at US$ 132.6 million in 2019 and is projected to reach US$ 204.3 million by 2027; it is expected to grow at a CAGR of 5.7% from 2020 to 2027.

Microtome is a device used for sample preparation in laboratories. The devices are used to slice biological specimens into evenly thin sections for a detailed microscopic examination. The microtome market is expected to witness huge growth during the forecast period on the back of the rising prevalence of cancer and increasing adoption of digital pathology. Moreover, growing focus on personalized medicine is further expected to foster the market growth in the coming years. However, the lack of adoption of microtome in low-income countries limits the growth of the market.

Get sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00006522/

Company Profiles

  • PHC Holdings Corporation
  • MEDITE Medical GmbH
  • Sakura Finetek USA, Inc.
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Histo-Line Laboratories
  • SLEE medical GmbH
  • Diapath S.p.A.
  • Amos Scientific Pty Ltd
  • Boeckeler Instruments, Inc.
  • SM Scientific Instruments Pvt. Ltd

The global microtome market, based on product, is segmented into microtome instruments and microtome accessories. The microtome instruments segment held a larger share of the market in 2019, and it is further estimated to register a higher CAGR during the forecast period; this projected growth is ascribed to the increasing product launches, growing adoption of microtome in histology labs, and high use of these instruments by healthcare providers in cancer diagnosis.

Moreover, growing awareness programs undertaken by organizations such as National Cervical Cancer Coalition, World Health Organization (WHO), and the Centers for Disease Control and Prevention (CDC) for cancer screening is further driving the market growth. For instance, the National Health Service (NHS) offers cervical screening programs for all women between 25 and 64 years of age in the UK. Also, Cancer Council Australia has recommended mammography as screening tool for the early detection of breast cancer. The screening program-BreastScreen Australia-allows women aged 50-74 to get free mammograms in every two years. As per the BreastScreen Australia, over 1.8 million women aged 50-74 participated in the screening program in 2017-2018. Thus, the aforementioned factors have led to an increased adoption of histopathology and tissue sectioning instruments, in turn, propelling the market growth.

Technology-Based Insights

Based on technology, the microtome market is segmented into manual microtomes, semi-automated microtomes, and fully automated microtomes. The fully automated microtomes segment held the largest share of the market in 2019 owing to growing demand for technologically advanced products, especially in developed economies. Additionally, the presence of commercially available fully automated systems and increasing preference for the digitalization of tissue diagnostic procedures are crucial factors boosting the growth of the market for this segment. A few of the automated products are Tissue-Tek Auto Section Automated Microtome and PT-PC Power Tomes. Further, the segment is anticipated to register the highest CAGR during the forecast period.

End User-Based Insights

Based on end user, the microtome market is segmented into hospitals, clinical laboratories, and other end users. The clinical laboratories segment held the largest share of the market in 2019; however, the market or other end users is anticipated to grow at the highest CAGR during the forecast period. The growth of the market for this segment is attributed to the increasing number of chronic diseases and rising awareness about the importance of early diagnosis, especially in low-income countries. Furthermore, as the demand for healthcare is increasing, the microtome market for the clinical laboratory segment is also expected to grow significantly in the coming years.

Strategic Insights

Product launches, mergers and acquisitions, collaborations, and expansions are the commonly adopted strategies by various companies to expand their footprint worldwide and meet the growing demand by expanding their respective product portfolios. The players operating in the microtome market adopted the strategy of product innovations to cater to changing customer demand worldwide, which also permits them to maintain their brand name globally.

Purchase Copy of This Report at: https://www.theinsightpartners.com/buy/TIPRE00006522/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Information:

Contact Us:
Call: +1-646-491-9876
Email: [email protected]


iCrowdNewswire

Keywords:    Microtome Market, Microtome